Milton Brown
Co-FounderDr. Milton Brown, M.D., Ph.D., CSC, FNAI, is a Co-Founder of Shuttle Pharmaceuticals Holdings, Inc. and served as Chief Scientific Officer for Chemistry and had been a Member of Board of Directors since its formation in December 2012 until February 28, 2028. Since August 2022, Dr. Brown has also served as Vice Dean of Research, Professor of Internal Medicine and the Prudence and Louis Ryan endowed chair in translational research at Eastern Virginia Medical School. Previously, he was Director of the Center for Drug Discovery at the George Mason University from 2020 to 2022 and Director of the Inova Center for Drug Discovery and Development from 2016 to 2020. Dr. Brown founded Rivanna Pharmaceuticals Inc. in 2004. He is co-founder, Chairman and CEO of Trocar Pharma in 2020, both of which are Virginia-based biopharmaceutical companies engaged in the discovery and development of novel small molecule therapeutics for the treatment of neurological, oncological and infectious diseases. Since 2012 until 2016, Dr. Brown has served as Director of the Drug Discovery Center at Georgetown University Medical School and since 2010 until 2015, he has been the principal investigator of the NIH/NCI funded Chemical Diversity Center. Dr. Brown has experience in the field of innovative drug discovery with over 80 publications and eight issued patents, including discovery of novel HDAC inhibitors and has two drugs currently in clinical trials. He is a tenured, Associate Professor of Chemistry and Neurology at the University of Virginia, where he supervises a team of 20 scientists in drug discovery and synthesis. Dr. Brown has won R01 grant support from the National Institutes of Health and additionally serves as a member of the NIH Drug Discovery and Molecular Pharmacology study section. He has served on government committees including the NIH Experimental Therapeutics Study Section, the NIH Drug Discovery and Molecular Pharmacology Study Section and was a scientific counselor to the U.S. Secretary of Health. He is a nationally respected expert in the field of drug discovery and has been invited to speak at numerous large biotechnology and pharmaceutical companies including Amgen, Lexicon and Merck. Prior to joining the faculty at UVA, Dr. Brown completed a postdoctoral study under Dr. Timothy Macdonald at the University of Virginia where he was supported by an NIH and a UNCF/Merck fellowship. Before that, Dr. Brown earned his M.D. degree from the University of Virginia where he was awarded the University’s Pratt Scholarship. Prior to medical school, Milton received his Ph.D. in Organic Chemistry & Synthetic Chemistry from the University of Alabama at Birmingham under Dr. Wayne Brouillette, 2003 chair of the American Chemical Society Medicinal Chemistry Division. Dr. Brown is additionally a graduate of the Harvard Health Professions Program and Oakwood College.
Positions
- Company NameShuttle Pharmaceuticals Holdings, Inc.Stock CodeSHPHPositionCo-FounderColleagues
- CRChristopher Robert CooperInterim Co-CEO & Director
- GSGeorge ScorsisIndependent Chairman of the Board
- RTRyan TrasoliniCo-Chief Executive Officer
- MJMira JungCo-Founder & Chief Scientific Officer for Biology
- YLYuying LiangChief Financial Officer
- TLTheodore L. PhillipsChairman of Scientific Advisory Committee
- ALAngel LirianoIndependent Director
- JMJ. Martin BrownMember of Scientific Advisory Committee
